Badar Yasin

Associate

Badar Yasin

Badar Yasin

Associate

Bar Admissions
  • New York, 2019
    Ontario, 2015

Badar is developing a broad practice in litigation and competition law.

He has acted for clients on mergers, cartels and abuse of dominance investigations; foreign investment reviews; distribution and pricing practices; and misleading advertising matters.

Badar previously worked as in-house legal counsel for a global fintech solutions company in Toronto. In 2016, he was seconded to General Motors as part of Davies' secondment program.

Badar Yasin

Associate

Badar is developing a broad practice in litigation and competition law.

He has acted for clients on mergers, cartels and abuse of dominance investigations; foreign investment reviews; distribution and pricing practices; and misleading advertising matters.

Badar previously worked as in-house legal counsel for a global fintech solutions company in Toronto. In 2016, he was seconded to General Motors as part of Davies' secondment program.

The Sherwin-Williams Company

Acted as Canadian counsel to The Sherwin-Williams Company on competition and regulatory matters in connection with its US$11.3-billion acquisition of The Valspar Corporation.

Alimentation Couche-Tard Inc.

Acted for Alimentation Couche-Tard Inc. in connection with (1) its acquisition of, by way of merger, the Texas-based gas-and-convenience-store chain CST Brands, Inc., valued at approximately US$4.4 billion; and (2) Alimentation Couche-Tard Inc.'s subsequent sale of a portion of CST Brands, Inc.'s Canadian assets to Parkland Fuel Corporation for approximately US$750 million, subject to adjustments.

Pfizer Inc.

Acted as Canadian counsel to Pfizer Inc. on competition and regulatory matters in connection with Pfizer's proposed US$160-billion acquisition of Allergan Plc.

Teva Pharmaceutical Industries Ltd.

Acted as Canadian counsel to Teva Pharmaceutical Industries Ltd. on competition and regulatory matters in connection with Teva's US$40.5-billion acquisition of Allergan Plc's generic pharmaceuticals business.

Actavis plc

Acted as Canadian counsel to Actavis plc on competition and regulatory matters in connection with its US$66 billion acquisition of Allergan, Inc.

Pfizer Inc.

Acted as Canadian counsel to Pfizer Inc. on competition and regulatory matters in connection with its $17-billion acquisition of Hospira Inc., a leading provider of injectable drugs, infusion technologies and biosimilars.

ZF Friedrichshafen AG

Acted as Canadian counsel to ZF Friedrichshafen AG on competition and other regulatory matters in its acquisition of TRW Automotive Holdings Corp. for approximately US$12.1 billion.

Bulletin

Suspension of Private Relief: CASL’s Private Right of Action Delayed

June 09, 2017 - Since its implementation in July 2014, Canada’s anti-spam law, or CASL, has continued to generate a fair amount of controversy due to its broad application and the availability of significant administrative monetary penalties. As we described in prior publications (The Other Shoe Drops: The...

Bar Admissions

New York, 2019
Ontario, 2015

Education

Queen’s University, JD, 2014
McGill University, BSc, 2010

Professional Affiliations

International Association of Privacy Professionals

Badar is developing a broad practice in litigation and competition law.

He has acted for clients on mergers, cartels and abuse of dominance investigations; foreign investment reviews; distribution and pricing practices; and misleading advertising matters.

Badar previously worked as in-house legal counsel for a global fintech solutions company in Toronto. In 2016, he was seconded to General Motors as part of Davies' secondment program.

The Sherwin-Williams Company

Acted as Canadian counsel to The Sherwin-Williams Company on competition and regulatory matters in connection with its US$11.3-billion acquisition of The Valspar Corporation.

Alimentation Couche-Tard Inc.

Acted for Alimentation Couche-Tard Inc. in connection with (1) its acquisition of, by way of merger, the Texas-based gas-and-convenience-store chain CST Brands, Inc., valued at approximately US$4.4 billion; and (2) Alimentation Couche-Tard Inc.'s subsequent sale of a portion of CST Brands, Inc.'s Canadian assets to Parkland Fuel Corporation for approximately US$750 million, subject to adjustments.

Pfizer Inc.

Acted as Canadian counsel to Pfizer Inc. on competition and regulatory matters in connection with Pfizer's proposed US$160-billion acquisition of Allergan Plc.

Teva Pharmaceutical Industries Ltd.

Acted as Canadian counsel to Teva Pharmaceutical Industries Ltd. on competition and regulatory matters in connection with Teva's US$40.5-billion acquisition of Allergan Plc's generic pharmaceuticals business.

Actavis plc

Acted as Canadian counsel to Actavis plc on competition and regulatory matters in connection with its US$66 billion acquisition of Allergan, Inc.

Pfizer Inc.

Acted as Canadian counsel to Pfizer Inc. on competition and regulatory matters in connection with its $17-billion acquisition of Hospira Inc., a leading provider of injectable drugs, infusion technologies and biosimilars.

ZF Friedrichshafen AG

Acted as Canadian counsel to ZF Friedrichshafen AG on competition and other regulatory matters in its acquisition of TRW Automotive Holdings Corp. for approximately US$12.1 billion.

Bulletin

Suspension of Private Relief: CASL’s Private Right of Action Delayed

June 09, 2017 - Since its implementation in July 2014, Canada’s anti-spam law, or CASL, has continued to generate a fair amount of controversy due to its broad application and the availability of significant administrative monetary penalties. As we described in prior publications (The Other Shoe Drops: The...

Bar Admissions

New York, 2019
Ontario, 2015

Education

Queen’s University, JD, 2014
McGill University, BSc, 2010

Professional Affiliations

International Association of Privacy Professionals